60
Antibody based assay – Pitfall and practical issue 2012 05 30 Seok-Hyung Kim

2012 05 30 Seok-Hyung Kim

  • Upload
    naida

  • View
    62

  • Download
    0

Embed Size (px)

DESCRIPTION

Antibody based assay –Pitfall and practical issue. 2012 05 30 Seok-Hyung Kim. Antibody based assay. 1. The chemical basis for Ab -reaction 2. How to choose good antibody 3. How to reduce non-specific reaction. Structure of Antibody. Heavy chain :Variable region + constant region - PowerPoint PPT Presentation

Citation preview

Page 1: 2012 05 30 Seok-Hyung  Kim

Antibody based assay –Pit-fall and practical issue

2012 05 30

Seok-Hyung Kim

Page 2: 2012 05 30 Seok-Hyung  Kim

Antibody based assay

1. The chemical basis for Ab-reaction2. How to choose good antibody3. How to reduce non-specific reaction

Page 3: 2012 05 30 Seok-Hyung  Kim

Structure of Antibody • Heavy chain :Variable region + constant region (isotype ) => class of antibody • Light chain : Variable region + constant region (kappa / lambda chain)

Page 4: 2012 05 30 Seok-Hyung  Kim

Structure of antibody

Page 5: 2012 05 30 Seok-Hyung  Kim
Page 6: 2012 05 30 Seok-Hyung  Kim
Page 7: 2012 05 30 Seok-Hyung  Kim
Page 8: 2012 05 30 Seok-Hyung  Kim

Beta pleated sheet containing two anti-Parallel beta strands

Page 9: 2012 05 30 Seok-Hyung  Kim

Immunoglobulin fold

Page 10: 2012 05 30 Seok-Hyung  Kim
Page 11: 2012 05 30 Seok-Hyung  Kim

Structure of Mouse IgG2a

Page 12: 2012 05 30 Seok-Hyung  Kim

Structure of a whole antibody

Page 13: 2012 05 30 Seok-Hyung  Kim
Page 14: 2012 05 30 Seok-Hyung  Kim

Computer simulation of an antibody-antigenInteraction between antibody and influenzaVirus antigen(a globular protein)

Ab-Ag interaction

Page 15: 2012 05 30 Seok-Hyung  Kim

Ag contact area : flat undulating face

• 650 – 900 A (15 – 22 amino acid)• small antigen : antigen binding site is gener-

ally smaller and appear more like a deep pocket in which ligand is largely buried

Page 16: 2012 05 30 Seok-Hyung  Kim

Unbound Fab fragment Bound Fab fragment

Solvent accessible surface of an anti-hemagglutinin Fab fragment

Page 17: 2012 05 30 Seok-Hyung  Kim

Flexibility of the Fab and Fc regions

Page 18: 2012 05 30 Seok-Hyung  Kim

Maturation of an antibody re-sponse is governed by modula-

tions in flexibility of antigen com-bining site

(immunity 2000 13: 611-620)

Pliable germline antigen combining site

epitope templated structural rigidity

maturation

Page 19: 2012 05 30 Seok-Hyung  Kim

Result (1)• Temperature dependence of antigen

affinities of antibodies from primary and secondary responses

• 25 -> 35’C : IgM : affinity 3 – 100 folds decrease IgG : No difference ; Qualitative difference

Page 20: 2012 05 30 Seok-Hyung  Kim

Table 1 Tempera-ture depen-dance

Model syn-thetic peptide antigen : PS1CT3

Page 21: 2012 05 30 Seok-Hyung  Kim

• Temperature differentially affects antigen association rates of primary and sec-ondary mAbs

Page 22: 2012 05 30 Seok-Hyung  Kim

Result(2) The cause of contradictory Effects of Temperature on

Antigen Association Rates between Primary and Secondary Responses : Change of Entropy

G= H-TS • Enthalpy(H) : Heat change

• Entrophy(S) : net conformational, stereochemical structural perturbations

Page 23: 2012 05 30 Seok-Hyung  Kim

• Covalent bond : not used• Hydrogen bond : important for Ag-Ab• Ionic bond : infrequently used• Van derwaals bond : frequently used

but not important• Hydrophobic interaction : important for

Ag-Ab

Chemical bond used in Ag-Ab in-teraction (1)

Page 24: 2012 05 30 Seok-Hyung  Kim

Result (2)

• Primary Ab(IgM) : enthalpy diriven entropy constrained • Secondary Ab : entropy driven Enthalpy 란 면에선 불리

Page 25: 2012 05 30 Seok-Hyung  Kim

Result(3)

• Germ line antibody 7cM(PS1CT3), 36-65(Ars), BBE6.12H3(NP)

37’C : high degree of cross reactivity 4’C : no cross reactivity

• Mature antibody Cys18(PS1CT3), P16.7(Ars), Bg110-2(NP)

37’C, 4’C : no cross reactivity

Page 26: 2012 05 30 Seok-Hyung  Kim

Discussion(1)

• Germ line antibody affinity at high temperature cross reactivity at high temperature

=> multiple conformational state > induced fit trasition from one conformation to another

Page 27: 2012 05 30 Seok-Hyung  Kim

Discussion (2)

• Entropic constraint of germline Ab. : Free germline paratope exist in an equilibrium between multiple conformational states, only subset of which are capable of binding to the Ag

Page 28: 2012 05 30 Seok-Hyung  Kim

Molecular dynamics and free energy cal-culations applied to affinity maturation In

antibody 48G7

Increasing the rigidity of the antibody structure further optimizes the binding affinity of the antibody for the hapten

(PNAS 1999 96: 14330)

Page 29: 2012 05 30 Seok-Hyung  Kim

rms fluctuations of the germ line and mature antibody hapten complexes. rms fluctuations are defined as rms deviations of the structure at a given time from the average structure of the MD simulation (PNAS 1999 96: 14330)

Page 30: 2012 05 30 Seok-Hyung  Kim

Structural Insights into the Evolution of an Antibody Com-

bining Site

Many germline antibodies may in-deed adopt multiple configurations with antigen binding, together with somatic mutation, stabilizing the configuration with optimum com-plementarity to antigen

(Science 1997 : 276; 1665)

Page 31: 2012 05 30 Seok-Hyung  Kim

ConclusionFlexibility Rigidity

Germline AbVersatileLow affinityScreening &recognitionTemperature sensitivePolyspecificMultiple configuration

Secondary AbSpecificHigh affinityResponseCross-reactive

Page 32: 2012 05 30 Seok-Hyung  Kim

1. Immunohistochemisty2. Flow cytometric analysis 3. Immunoprecipitation (IP, ChIP)4. ELISA

Applications of Anti-body

1. Immunoblotting (Western blotting)

3D conformation Linear form

Types of antigen (epitope)

Page 33: 2012 05 30 Seok-Hyung  Kim

Antibody based assay

1. The chemical basis for Ab-reaction2. How to choose good antibody3. How to reduce non-specific reaction

Page 34: 2012 05 30 Seok-Hyung  Kim

How to choose good antibody

• A good antibody?: High affinity: Entropy driven antibody

• A good antibody : low risk-low return: generally expensive (DAKO, Novo…): restriction in variety

Page 35: 2012 05 30 Seok-Hyung  Kim

How to choose good antibody

• A bad antibody: High risk-high return: generally less expensive (santa cruz): much less restriction in variety: but require highly skillful ex-pert.

Page 36: 2012 05 30 Seok-Hyung  Kim

항체를 저농도로 사용시

Control

측정값

Control

측정값

항체를 고농도로 사용시

역가가 낮은 항체

Control

측정값

Control

측정값

역가가 높은 항체

항체를 저농도로 사용시 항체를 고농도로 사용시

Good antibody / bad antibody

Page 37: 2012 05 30 Seok-Hyung  Kim

• Bad antibody : structurally more flexible 37’C : high degree of cross reactivity

: multiple conformational state 4’C : no cross reactivity

• Good antibody : more rigid 37’C, 4’C : no cross reactivity

Structural difference in good / bad antibody (1)

Page 38: 2012 05 30 Seok-Hyung  Kim

Flexibility RigidityGermline AbVersatileLow affinityTemperature sensitivePolyspecificMultiple configuration

Secondary AbSpecificHigh affinitycross-reactive

Structural difference in good / bad antibody (2)

Page 39: 2012 05 30 Seok-Hyung  Kim

Antibody based assay

1. The chemical basis for Ab-reaction2. How to choose good antibody3. How to reduce non-specific reaction

Page 40: 2012 05 30 Seok-Hyung  Kim

- Polyspecificity (Multi-specificity) : unrelated specificities, which means interactions caused by different binding modes.

- Cross-reactivity (Molecular mimicry)

: interactions based on wild-type-derived key residues.

Non-specific reactivity of An-tibody

(Unwanted reactivity)

Page 41: 2012 05 30 Seok-Hyung  Kim

1. Unwanted reaction of Antibody

2. Non-specific reaction of detection kit

3. Non-opitimized buffer

Causes of non-specific reac-tivity of Antibody based as-

say

Page 42: 2012 05 30 Seok-Hyung  Kim

1. Selection of good Antibody

2. Optimization of antibody dilution

3. Simple but sensitive detection kit

4. Opitimization of buffer (ion concentration / blocking agent)

Solution of non-specific reac-tivity of Antibody based as-

say

Page 43: 2012 05 30 Seok-Hyung  Kim

Positive con-trol

Negative control

Page 44: 2012 05 30 Seok-Hyung  Kim

Causes of background staining in immunohistochemistry

1. Non-specific interaction between SA-HRP and tissue : ionic interaction

hydrophobic interaction

2. Endogenous biotin

3. Binding of SA-HRP to endogenous lectin

3. Non-specific interaction of 2ndary antibody

Page 45: 2012 05 30 Seok-Hyung  Kim

SPECIFIC ANTIBODY

NON-SPECIFIC ANTIBODY

CONCENTRATION

AMO

UN

T BO

UN

D

TITERING ANTIBODIES

Page 46: 2012 05 30 Seok-Hyung  Kim

3

3 µgs/n = 2.5

1 µgs/n = 2.1

0.3 µgs/n = 2.4

0.1 µgs/n = 4.1

0.03 µgs/n = 4.8

0.01 µgs/n = 4.6

0.003 µgs/n = 3.5

0.001 µgs/n = 3.2

auto

Page 47: 2012 05 30 Seok-Hyung  Kim

8765432102

3

4

5

Dilution

Sign

al t

o N

oise

TITER

Page 48: 2012 05 30 Seok-Hyung  Kim

101 102 103 104101 102 103 104101 102 103 104

1 µg S/NAb 278IC 5.8

isotypecontrol

antibody

cytokeratin.3 µg S/NAb 100IC 3.6

101 102 103 104

.01 µg S/NAb 25.7IC 2.6

num

ber

Page 49: 2012 05 30 Seok-Hyung  Kim

면역조직화학의 주요문제: 비특이적 배경염색의 원인

1PBSNaCl : 150mM

1/10 PBSNaCl : 15mM

Lymph node : L26(anti-CD20; B cell marker)

Page 50: 2012 05 30 Seok-Hyung  Kim

The enhanced reactivity of endogenous bi-otin-like molecules by the antigen retrieval procedures and signal amplification with

tyramine

Seok Hyung Kim1, Kyeong Cheon Jung2 , Young Kee Shin1,4, Kyung Mee Lee4, Young S. Park1, Yoon La Choi1, Kwon Ik

Oh1, Min Kyung Kim1, Doo Hyun Chung1, Hyung Geun Song3,4 & Seong Hoe Park1,*

Histochemical journal 2002 34;97-103

Page 51: 2012 05 30 Seok-Hyung  Kim

DAB

:Horseradish Peroxidase (HRP)

Bb

: Streptavidin

: Biotin

Bb BbBb

Schematic drawings of principle of false positive stain-ing

due to endogenous biotin

Page 52: 2012 05 30 Seok-Hyung  Kim

(A) (B) : with Microwave heaing

(A) ductal cell of

mammary gland

(B) gland of seminal vesicle

(C)(D) : with heating

under pressure

(C) Neurons of cerebrum

(D) thyrocyte of thyroid

Figure 2. Immunostaining of normal human tissues using HRP-conjugated streptavidin only with microwave heating or heating under pressure

as an antigen retrieval method.

Page 53: 2012 05 30 Seok-Hyung  Kim

(A) No antigen retrieval

(B) Heating under pressure

(C) Signal amplification with

biotinylated tyramine

(D) Immunostaining with

anti-biotin antibody

Figure 3. . Immunostaining of normal human tissues using anti-biotin antibodies or signal amplification technique

without antigen retrieval treatment.

Page 54: 2012 05 30 Seok-Hyung  Kim

An Improved Protocol of Biotinylated Tyramine-based Immunohistochemistry

Minimizing Nonspecific Background Stain-ing

Seok Hyung Kim1, Young Kee Shin2 , Kyung Mee Lee1,4, Jung Sun Lee4, Ji Hye Yun1,

Journal of Histochemistry & Cytochemistry 2003 51;129-131

Page 55: 2012 05 30 Seok-Hyung  Kim

B

: Streptavidin

:HorseradishPeroxidase (HRP)

:Biotin

B

SecondaryAb

Primary Ab

B

B

B

B :Biotinyl tyramide

Schematic drawings of priciple of TyramineBased signal amplified immunohistochemistry

Page 56: 2012 05 30 Seok-Hyung  Kim

Figure 1. Background staining of a normal lymph node in various conditions.

(A)SA-HRP DAB

(B) B-T SA-HRP DAB

(C) SA-HRP B-T SA-HRP

DAB

(D) 2’ Ab SA-HRP B-T

SA-HRP DAB

Page 57: 2012 05 30 Seok-Hyung  Kim

Figure 2. Suppression of background staining induced by HRP-conjugated streptavidin

by several kinds of blocking agents.

(A)Bovine serum albu-min

(B) Goat globulin

(C) Skim milk

(D) Casein sodium salt

(E) Trypton casein pep-ton

Page 58: 2012 05 30 Seok-Hyung  Kim

Figure 3. Suppression of background staining induced by biotinyl goat anti-mouse antibody

by several kinds of blocking agents..

(A)Bovine serum albu-min

(B) Goat globulin

(C) Skim milk

(D) Casein sodium salt

(E) Trypton casein pep-ton

Page 59: 2012 05 30 Seok-Hyung  Kim

Figure 4. Effects of washing buffer on suppression of background staining

(A)Imidazole buffer

(B) PBS

(C) Tris buffer

(D) Distilled water

(E) Borate buffer

(F) Citrate buffer

Page 60: 2012 05 30 Seok-Hyung  Kim

Figure 5. Immunostaining of human lymph node tissues with anti-CD20 antibodies under various blocking conditions.

(A) Conventional im-munostaining

(B) Tyramide-based

immunostaining

(C) Modified protocol

of tyramide-based

immunostaining